Drug Discovery Department, Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, United States.
ACS Chem Biol. 2012 Apr 20;7(4):698-706. doi: 10.1021/cb200508b. Epub 2012 Jan 27.
Most protein kinases share a DFG (Asp-Phe-Gly) motif in the ATP site that can assume two distinct conformations, the active DFG-in and the inactive DFG-out states. Small molecule inhibitors able to induce the DFG-out state have received considerable attention in kinase drug discovery. Using a typical DFG-in inhibitor scaffold of Aurora A, a kinase involved in the regulation of cell division, we found that halogen and nitrile substituents directed at the N-terminally flanking residue Ala273 induced global conformational changes in the enzyme, leading to DFG-out inhibitors that are among the most potent Aurora A inhibitors reported to date. The data suggest an unprecedented mechanism of action, in which induced-dipole forces along the Ala273 side chain alter the charge distribution of the DFG backbone, allowing the DFG to unwind. As the ADFG sequence and three-dimensional structure is highly conserved, DFG-out inhibitors of other kinases may be designed by specifically targeting the flanking alanine residue with electric dipoles.
大多数蛋白激酶在 ATP 结合位点共享一个 DFG(天冬氨酸-苯丙氨酸-甘氨酸)基序,该基序可以呈现两种截然不同的构象,即活性的 DFG-in 和非活性的 DFG-out 状态。能够诱导 DFG-out 状态的小分子抑制剂在激酶药物发现中受到了广泛关注。我们使用 Aurora A(一种参与细胞分裂调节的激酶)的典型 DFG-in 抑制剂骨架,发现针对 N 端侧翼残基 Ala273 的卤素和腈取代基诱导了酶的全局构象变化,导致 DFG-out 抑制剂成为迄今为止报道的最有效的 Aurora A 抑制剂之一。这些数据表明了一种前所未有的作用机制,其中沿 Ala273 侧链的诱导偶极力改变了 DFG 骨架的电荷分布,从而使 DFG 解旋。由于 ADFG 序列和三维结构高度保守,因此可以通过用偶极子特异性靶向侧翼丙氨酸残基来设计其他激酶的 DFG-out 抑制剂。